Intrua Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Intrua Financial's BMY Position: Q2 2026 in Review
Intrua Financial reduced its Bristol-Myers Squibb (BMY) stake by 7.7% in Q2 2026, selling an estimated $92.9K and leaving 19,442 shares worth $1.12M. The position accounts for 0.1% of the portfolio, ranked #147.
Intrua Financial first reported a position in BMY in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.38M in Q1 2025. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Intrua Financial held 19,442 shares of Bristol-Myers Squibb worth $1.12M as of Q2 2026.
- Intrua Financial sold 1,618 Bristol-Myers Squibb shares in Q2 2026, an estimated $92.9K.
- Bristol-Myers Squibb made up 0.1% of Intrua Financial's portfolio in Q2 2026, its #147 holding.
- Intrua Financial first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 21 quarters since.
- Intrua Financial's Bristol-Myers Squibb position peaked at $1.38M in Q1 2025.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Intrua Financial's 13F filing for Q2 2026, filed 24 Jul 2026.